全文获取类型
收费全文 | 186311篇 |
免费 | 16943篇 |
国内免费 | 8487篇 |
专业分类
耳鼻咽喉 | 2545篇 |
儿科学 | 4082篇 |
妇产科学 | 2260篇 |
基础医学 | 32953篇 |
口腔科学 | 5529篇 |
临床医学 | 14709篇 |
内科学 | 25135篇 |
皮肤病学 | 4629篇 |
神经病学 | 10103篇 |
特种医学 | 4546篇 |
外国民族医学 | 118篇 |
外科学 | 16514篇 |
综合类 | 28954篇 |
现状与发展 | 48篇 |
预防医学 | 5327篇 |
眼科学 | 3585篇 |
药学 | 14350篇 |
33篇 | |
中国医学 | 5642篇 |
肿瘤学 | 30679篇 |
出版年
2024年 | 322篇 |
2023年 | 2482篇 |
2022年 | 4696篇 |
2021年 | 6628篇 |
2020年 | 5916篇 |
2019年 | 5568篇 |
2018年 | 5785篇 |
2017年 | 6194篇 |
2016年 | 6526篇 |
2015年 | 7390篇 |
2014年 | 11113篇 |
2013年 | 12084篇 |
2012年 | 10701篇 |
2011年 | 11980篇 |
2010年 | 9952篇 |
2009年 | 9561篇 |
2008年 | 10012篇 |
2007年 | 10234篇 |
2006年 | 9247篇 |
2005年 | 8453篇 |
2004年 | 7476篇 |
2003年 | 6482篇 |
2002年 | 5314篇 |
2001年 | 4667篇 |
2000年 | 3813篇 |
1999年 | 3473篇 |
1998年 | 3199篇 |
1997年 | 2948篇 |
1996年 | 2624篇 |
1995年 | 2316篇 |
1994年 | 2026篇 |
1993年 | 1630篇 |
1992年 | 1329篇 |
1991年 | 1230篇 |
1990年 | 980篇 |
1989年 | 900篇 |
1988年 | 844篇 |
1987年 | 665篇 |
1986年 | 608篇 |
1985年 | 824篇 |
1984年 | 749篇 |
1983年 | 511篇 |
1982年 | 534篇 |
1981年 | 430篇 |
1980年 | 377篇 |
1979年 | 291篇 |
1978年 | 197篇 |
1977年 | 147篇 |
1976年 | 114篇 |
1973年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
61.
62.
63.
Luis Veloza Cristina Teixido Natalia Castrejon Fina Climent Ana Carri Marta Marginet Davide Soldini Blanca Gonzlez‐Farr Inmaculada Ribera‐Cortada Armando Lopez‐Guillermo Eva Gonzlez‐Barca Adriana Sierra Mileyka Herrera Cndida Gmez Adriana Garcia Olga Balagu Elias Campo Antonio Martinez 《Histopathology》2019,75(6):799-812
64.
65.
66.
《International journal of oral and maxillofacial surgery》2021,50(11):1422-1428
It is clinically challenging to identify oral leukoplakias that have a high risk of undergoing malignant transformation. The aim of this retrospective study was to elucidate the associations between malignant transformation of oral leukoplakias and various clinicopathologic factors. Patients with a diagnosis of clinical oral leukoplakia, verified through histopathologic examination and with access to digital images of the lesion, were retrospectively included for the period 2003–2013. Using the clinical images, all lesions were re-evaluated regarding diagnosis and clinical subtype. Of the 234 included patients, with a median follow-up of 9 years, 27 (11.5%) developed oral squamous cell carcinoma. Among the clinicopathologic factors investigated, non-homogeneous oral leukoplakia (OL), OL with dysplasia, and OL localized to the tongue showed statistically significant increased rates of malignant transformation in the multivariate Cox regression analysis. Non-homogeneous OL showed a 15.2-times higher transformation rate than homogenous OL (P < 0.001). Dysplastic leukoplakias developed into carcinomas 2.4-times more often than did non-dysplastic leukoplakias (P = 0.048). OL located on the tongue showed a 2.8-times higher malignant transformation rate than OLs at other oral locations (P = 0.018), when other locations were combined into one group. Non-homogeneous OL, OL with dysplasia, and OL localized to the tongue have higher transformation rates. 相似文献
67.
目的 探讨人格特征对喉鳞状细胞癌(LSCC)患者术后近期心理健康状况的影响。方法 纳入2017年1月—2019年12月在湖北省肿瘤医院行手术治疗的119例男性LSCC患者,术后5~7 d采用SCL-90、SAS、SDS自评量表评估术后心理状态,采用EPQ问卷测评患者的人格特征。多元线性逐步回归方法分析LSCC患者术后近期SAS和SDS评分的影响因素。结果 男性LSCC患者术后SCL-90、SAS、SDS得分显著高于中国常模(P≤0.05),EPQ中精神质(P)量表和神经质(N)量表得分高于中国常模(P<0.01)。男性LSCC患者术后躯体化、强迫、焦虑、抑郁、敌对、恐怖、偏执、精神病性因子得分均显著高于中国常模(P<0.05)。家庭收入、手术方式、术后近期是否行放化疗、P和N人格特征是术后SAS评分的影响因素(均P<0.01);家庭收入、手术方式、术后近期是否行放化疗和N人格特征是术后SDS评分的影响因素(P<0.01)。结论 LSCC患者术后近期存在抑郁、焦虑等心理障碍;具有P和N人格特征;家庭收入、手术方式、术后近期是否行放化疗以及P和N人格特征是影响术后SAS及SDS评分的独立危险因素。 相似文献
68.
69.
70.
《Vaccine》2019,37(31):4302-4309
Influenza A virus (IAV) vaccines in pigs generally provide homosubtypic protection but fail to prevent heterologous infections. In this pilot study, the efficacy of an intradermal pDNA vaccine composed of conserved SLA class I and class II T cell epitopes (EPITOPE) against a homosubtypic challenge was compared to an intramuscular commercial inactivated whole virus vaccine (INACT) and a heterologous prime boost approach using both vaccines. Thirty-nine IAV-free, 3-week-old pigs were randomly assigned to one of five groups including NEG-CONTROL (unvaccinated, sham-challenged), INACT-INACT-IAV (vaccinated with FluSure XP® at 4 and 7 weeks, pH1N1 challenged), EPITOPE-INACT-IAV (vaccinated with PigMatrix EDV at 4 and FluSure XP® at 7 weeks, pH1N1 challenged), EPITOPE-EPITOPE-IAV (vaccinated with PigMatrix EDV at 4 and 7 weeks, pH1N1 challenged), and a POS-CONTROL group (unvaccinated, pH1N1 challenged). The challenge was done at 9 weeks of age and pigs were necropsied at day post challenge (dpc) 5. At the time of challenge, all INACT-INACT-IAV pigs, and by dpc 5 all EPITOPE-INACT-IAV pigs were IAV seropositive. IFNγ secreting cells, recognizing vaccine epitope-specific peptides and pH1N1 challenge virus were highest in the EPITOPE-INACT-IAV pigs at challenge. Macroscopic lung lesion scores were reduced in all EPITOPE-INACT-IAV pigs while INACT-INACT-IAV pigs exhibited a bimodal distribution of low and high scores akin to naïve challenged animals. No IAV antigen in lung tissues was detected at necropsy in the EPITOPE-INACT-IAV group, which was similar to naïve unchallenged pigs and different from all other challenged groups. Results suggest that the heterologous prime boost approach using an epitope-driven DNA vaccine followed by an inactivated vaccine was effective against a homosubtypic challenge, and further exploration of this vaccine approach as a practical control measure against heterosubtypic IAV infections is warranted. 相似文献